Cargando…
Topical Application of Imiquimod as a Treatment for Chromoblastomycosis
Chromoblastomycosis is a subcutaneous mycosis that remains a therapeutic challenge, with no standard treatment and high rates of relapse. On the basis of our recent discoveries in mouse models, we tested the efficacy of topical applications of imiquimod to treat patients afflicted with this chronic...
Autores principales: | de Sousa, Maria da Glória Teixeira, Belda, Walter, Spina, Ricardo, Lota, Priscila Ramos, Valente, Neusa Sakai, Brown, Gordon D., Criado, Paulo Ricardo, Benard, Gil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036686/ https://www.ncbi.nlm.nih.gov/pubmed/24633683 http://dx.doi.org/10.1093/cid/ciu168 |
Ejemplares similares
-
Chromoblastomycosis Treated With Posaconazole and Adjunctive Imiquimod: Lending Innate Immunity a Helping Hand
por: Logan, Clare, et al.
Publicado: (2023) -
Chromoblastomycosis evolving to sarcomatoid squamous cell carcinoma: A case report
por: Belda Junior, Walter, et al.
Publicado: (2021) -
Cutaneous New World Leishmaniasis on a Port-wine stain
birthmark()
por: Criado, Paulo Ricardo, et al.
Publicado: (2014) -
In situ immune response in human dermatophytosis: possible role of Langerhans cells (CD1a+) as a risk factor for dermatophyte infection
por: Reis, Ana Paula Carvalho, et al.
Publicado: (2019) -
TOLL-LIKE RECEPTORS (TLR) 2 AND 4 EXPRESSION OF KERATINOCYTES FROM
PATIENTS WITH LOCALIZED AND DISSEMINATED DERMATOPHYTOSIS
por: de Oliveira, Cristiane Beatriz, et al.
Publicado: (2015)